News center
There is currently no information to display
Please add data record on website background.
-
HiRO News
There is currently no information to display
Please add data record on website background.
搜索

HiRO News

Case Study: Rescuing Vaccine study, achieving milestone 3 months early
Case Study: Rescuing Vaccine study, achieving milestone 3 months early
A biotech sponsor based in China was conducting a clinical study on COVID-19 treatment in the United States and the Asia Pacific region, including China, in collaboration with a global contract research organization (CRO). 6 months into a new study start, facing site activation and patient recruitment challenges, biotech changes CRO and HiRO rescues Vaccine study.
Read more >>
HiRO Acquires US CRO Courante Oncology,  Strengthens Global Footprint and Operation Capabilities
HiRO Acquires US CRO Courante Oncology, Strengthens Global Footprint and Operation Capabilities
Harvest Integrated Research Organization (HiRO), an innovation global CRO, is pleased to announce the successful acquisition of Courante Oncology, a US-based full-service clinical research provider specializing in oncology product development.
Read more >>
Pharma Tech Outlook Names HiRO as Top 10 CROs in APAC 2022
Pharma Tech Outlook Names HiRO as Top 10 CROs in APAC 2022
Harvest Integrated Research Organization (HiRO) is proud to announce that the highly regarded global pharmaceutical publication "Pharma Tech Outlook" named HiRO among the Top 10 CROs in Asia and the Pacific. 
Read more >>
Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in Series A Financing, to Offer Multinational Global Clinical Development Strategy
Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in Series A Financing, to Offer Multinational Global Clinical Development Strategy
HiRO announced the completion of its Series A financing in the tens of millions of US dollars. This round of investment is led by OrbiMed, with the participation from existing shareholder, Fontus Capital.
Read more >>
PKU and HiRO Are Partnering to Bring Medicine to Patients, Faster and Successfully.
PKU and HiRO Are Partnering to Bring Medicine to Patients, Faster and Successfully.
Read more >>
HiRO completes the acquisition of PharmaSols, expands its coverage in the Asia-Pacific region, improves clinical operation capabilities and international layout
HiRO completes the acquisition of PharmaSols, expands its coverage in the Asia-Pacific region, improves clinical operation capabilities and international layout
HiRO's acquisition of Pharmaceutical Solutions (PharmaSols or PSL), an agreement was formally signed in October 2021.
Read more >>
HiRO and CluePoints have reached a strategic cooperation to provide the most advanced RBQM expertise and services in the Chinese market
HiRO and CluePoints have reached a strategic cooperation to provide the most advanced RBQM expertise and services in the Chinese market
HiRO and CluePoints signed a partnership agreement to provide HiRO clients state-of-the-art Risk-Based Quality Management (RBQM) expertise and technical services in Greater China.
Read more >>
Previous page
1
×

搜索

Search
Logo

Tel:+86 21 62191220

Email :info@harvestiro.com

Add:33C2, Zhongyi Building, 
No. 580 Nanjing West Road, Shanghai

Copyright © 2022  Harvest Integrated Research Organization         沪ICP备2021009006号

×